| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,932 | 2,332 | 2,888 | 2,720 | | Cost of Revenue | 1,552 | 1,769 | 2,242 | 3,105 | | | Gross Profit | 380 | 563 | 646 | (385) | | | Operating Expenses | | Research Development | 78 | 91 | 112 | 117 | | Selling General and Administrative | 1,516 | 1,253 | 1,917 | 1,817 | | Non Recurring |
-
|
-
| 5,500 | 25,585 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,214) | (781) | (6,883) | (27,904) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 673 | (614) | 599 | | Earnings Before Interest And Taxes | (1,213) | (108) | (7,497) | (27,305) | | Interest Expense | 845 | 3,058 | 1,795 | 2,609 | | Income Before Tax | (2,058) | (3,166) | (9,292) | (29,914) | | Income Tax Expense | 6 | 822 |
-
| 2 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,064) | (3,988) | (9,292) | (29,916) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items | 12,913 |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,849 | (3,988) | (9,292) | (29,916) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,849 | ($3,988) | ($9,292) | ($29,916) |
|
0.49% Nasdaq 
Income Statement
